Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0000950144-07-004069
Filing Date
2007-05-01
Accepted
2007-05-01 17:29:14
Documents
38

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. g06286sv1.htm S-1 1660433
2 EX-3.1 SECOND AMENDED AND RESTATED CHARTER OF CUMBERLAND PHARMACEUTICALS INC. g06286exv3w1.htm EX-3.1 37444
3 EX-3.2 AMENDED AND RESTATED BYLAWS OF CUMBERLAND PHARMACEUTICALS INC. g06286exv3w2.htm EX-3.2 53459
4 EX-4.2 WARRANT TO PURCHASE COMMON STOCK g06286exv4w2.htm EX-4.2 44737
5 EX-4.4 WARRANT TO PURCHASE COMMON STOCK g06286exv4w4.htm EX-4.4 44666
6 EX-4.5 FORM OF OPTION AGREEMENT g06286exv4w5.htm EX-4.5 13412
7 EX-10.1 MANUFACTURING AND SUPPLY AGREEMENT g06286exv10w1.htm EX-10.1 91084
8 EX-10.2 NOVATION AGREEMENT g06286exv10w2.htm EX-10.2 17631
9 EX-10.3 FIRST AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT g06286exv10w3.htm EX-10.3 30545
10 EX-10.4 CARDINAL HEALTH CONTRACT SALES AND SERVICE g06286exv10w4.htm EX-10.4 120717
11 EX-10.5 FIRST AMENDMENT TO CONTRACT SALES AND SERVICE AGREEMENT g06286exv10w5.htm EX-10.5 17639
12 EX-10.6 CONSENT TO ASSIGNMENT g06286exv10w6.htm EX-10.6 10916
13 EX-10.7 DISTRIBUTION SERVICES AGREEMENT g06286exv10w7.htm EX-10.7 75568
14 EX-10.8 STRATEGIC ALLIANCE AGREEMENT g06286exv10w8.htm EX-10.8 161879
15 EX-10.9 KRISTALOSE AGREEMENT g06286exv10w9.htm EX-10.9 270143
16 EX-10.10 LICENSE AGREEMENT g06286exv10w10.htm EX-10.10 49552
17 EX-10.11 EMPLOYMENT AGREEMENT g06286exv10w11.htm EX-10.11 23037
18 EX-10.12 EMPLOYMENT AGREEMENT g06286exv10w12.htm EX-10.12 26689
19 EX-10.13 EMPLOYMENT AGREEMENT g06286exv10w13.htm EX-10.13 26486
20 EX-10.14 EMPLOYMENT AGREEMENT g06286exv10w14.htm EX-10.14 26603
21 EX-10.15 EMPLOYMENT AGREEMENT g06286exv10w15.htm EX-10.15 27807
22 EX-10.17 1999 STOCK OPTION PLAN g06286exv10w17.htm EX-10.17 42851
23 EX-10.20 FORM OF INDEMNIFICATION AGREEMENT g06286exv10w20.htm EX-10.20 17432
24 EX-10.21 LEASE AGREEMENT g06286exv10w21.htm EX-10.21 240210
25 EX-10.23 AMENDED AND RESTATED LEASE AGREEMENT g06286exv10w23.htm EX-10.23 96855
26 EX-10.24 FIRST AMENDMENT TO AMENDED AND RESTATED LEASE AGREEMENT g06286exv10w24.htm EX-10.24 10892
27 EX-21 SUBSIDIARIES OF CUMBERLAND PHARMACEUTICALS INC. g06286exv21.htm EX-21 2067
28 EX-23.1 CONSENT OF KPMG LLP g06286exv23w1.htm EX-23.1 2799
29 GRAPHIC g06286g0628602.gif GRAPHIC 3642
30 GRAPHIC g06286g0628610.gif GRAPHIC 337
31 GRAPHIC g06286g0628603.gif GRAPHIC 4723
32 GRAPHIC g06286g0628601.gif GRAPHIC 1414
33 GRAPHIC g06286g0628600.gif GRAPHIC 5123
34 GRAPHIC g06286g0628604.gif GRAPHIC 266089
35 GRAPHIC g06286g0628605.gif GRAPHIC 60583
36 GRAPHIC g06286g0628607.gif GRAPHIC 118986
37 GRAPHIC g06286g0628608.gif GRAPHIC 45257
38 GRAPHIC g06286g0628609.gif GRAPHIC 40884
  Complete submission text file 0000950144-07-004069.txt   3999870
Mailing Address
Business Address 209 TENTH AVENUE SOUTH SUITE 332 NASHVILLE, TN 37203
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1 | Act: 33 | File No.: 333-142535 | Film No.: 07807332